Dana-Farber

Dana-Farber

@DanaFarber

Followers100.8K
Following10.2K

Dana-Farber Cancer Institute - a leading center for expert, compassionate cancer care and advanced research. Appts: 877-442-3324 | https://t.co/8WMFTb5fDx

Boston, Massachusetts
Joined on June 30, 2008
Statistics

We looked inside some of the tweets by @DanaFarber and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
7 hours
Average replies
0
Average retweets
5
Average likes
16
Tweets with photos
35 / 100
Tweets with videos
25 / 100
Tweets with links
0 / 100

Rankings (sorted by number of followers)

9. in country United States and category Medical Center

24. in category Medical Center

181. in country United States and category Place

730. in category Place

Join Dana-Farber and The Jimmy Fund on September 25 for Revolutionary Developments in Women’s Cancers, a virtual presentation hosted by the Susan F. Smith Center Executive Council with WBZ-TV Anchor, 
@LisaWBZ

To learn more, visit: https://t.co/g6MMJ9sqhQ https://t.co/KcKHkDQ4co https://t.co/WCgWOyFk7U

Join Dana-Farber and The Jimmy Fund on September 25 for Revolutionary Developments in Women’s Cancers, a virtual presentation hosted by the Susan F. Smith Center Executive Council with WBZ-TV Anchor, @LisaWBZ To learn more, visit: https://t.co/g6MMJ9sqhQ https://t.co/KcKHkDQ4co https://t.co/WCgWOyFk7U

Cancer doesn't wait. Neither should you. https://t.co/kVzx7frf65

Studies led by @ColemanLindsley demonstrate how factors such as telomere length and telomerase mutations may affect outcomes in stem cell transplant recipients and patients with #MDS .

https://t.co/4dxA0kVAHq https://t.co/0jCHItlXA7

Studies led by @ColemanLindsley demonstrate how factors such as telomere length and telomerase mutations may affect outcomes in stem cell transplant recipients and patients with #MDS . https://t.co/4dxA0kVAHq https://t.co/0jCHItlXA7

Join DanaFarber and @TheJimmyFund on September 25 for Revolutionary Developments in Women’s Cancers, a virtual presentation hosted by the Susan F. Smith Center Executive Council with WBZ-TV Anchor, 
@LisaWBZ

To learn more, visit: https://t.co/MIvvS9D62B https://t.co/gz0Dje7n5I

Join DanaFarber and @TheJimmyFund on September 25 for Revolutionary Developments in Women’s Cancers, a virtual presentation hosted by the Susan F. Smith Center Executive Council with WBZ-TV Anchor, @LisaWBZ To learn more, visit: https://t.co/MIvvS9D62B https://t.co/gz0Dje7n5I

A new study details how actions taken at Dana-Farber enabled cancer #clinicaltrials to stay on track during the #COVID19 pandemic: https://t.co/0SCOiKePXl via @JNCI_Now https://t.co/pnXYGumpLj

A new study details how actions taken at Dana-Farber enabled cancer #clinicaltrials to stay on track during the #COVID19 pandemic: https://t.co/0SCOiKePXl via @JNCI_Now https://t.co/pnXYGumpLj

Endometriosis is a fairly common condition and some symptoms mirror those of #endometrialcancer, but how can you tell the difference? Learn more about symptoms and detection from #GYNcancer experts. #GCAM #endometriosis https://t.co/PSOtmBoNcK

The face of #colorectalcancer is changing. Today, incidence rates of colon and #rectalcancer are on the rise in young people. https://t.co/mUYMuPjvI8

World Marrow Donor Day was celebrated around the globe on Saturday. Join the virtual global donor drive at https://t.co/kq31WVS7vW. 

To learn more about Dana-Farber’s Donor Services, visit https://t.co/NeANRbKeX0 #WMDD2020 https://t.co/yvIZZ80hso

World Marrow Donor Day was celebrated around the globe on Saturday. Join the virtual global donor drive at https://t.co/kq31WVS7vW. To learn more about Dana-Farber’s Donor Services, visit https://t.co/NeANRbKeX0 #WMDD2020 https://t.co/yvIZZ80hso

In an investigator-initiated phase 1 study, Marlise Luskin, MD, MSCE explores dual ABL blockade to help prolong survival for patients with the challenging BCR-ABL+ #ALL diagnosis.  https://t.co/wiTTin5Qlb https://t.co/wO5HUehCSn

In an investigator-initiated phase 1 study, Marlise Luskin, MD, MSCE explores dual ABL blockade to help prolong survival for patients with the challenging BCR-ABL+ #ALL diagnosis. https://t.co/wiTTin5Qlb https://t.co/wO5HUehCSn

Breast cancer research at #ESMO20: Erica L, Mayer, MD, MPH (@elmayermd), discusses next steps after PALLAS study found no benefit of treating early HR+/HER2- #breastcancer with palbociclib and endocrine therapy compared to endocrine therapy alone 👇 https://t.co/RSSGRdxZjF

Breast Cancer Research: Dr. Mittendorf, MD, PhD (@EMittendorfMD) discusses the results from IMpassion031 trial which found benefit from an immunotherapy-chemotherapy combination for patients with early-stage triple-negative #breastcancer: https://t.co/LHSrw91OvG #ESMO20 https://t.co/nXJIUVg5fB

Prostate cancer research at #ESMO20: Christopher Sweeney, MBBS (@ChrisSweens1), on phase III trial results that show adding AKT inhibitor to abiraterone results in longer time to progression in metastatic castration-resistant #prostatecancer patients #PCSM https://t.co/O94lpi2ojh

Pivotal study presented at #ESMO20: Toni Choueiri, MD (@DrChoueiri), presents results from CheckMate 9ER that shows #immunotherapy combination improves outcomes in advanced kidney cancer: https://t.co/ygpWJtxXWe #kcsm https://t.co/YCIbmimYtQ

"The field of cancer therapy is being transformed by our deeper understanding of the genetic basis of cancer and the interactions between cancer and the immune system." More from our CMO, Craig Bunnell, MD, about innovation in #oncology, via @BeckersHR https://t.co/1C1HcSydsv

Learn the signs of symptoms of pancreatic cancer.

Leveraging her experience in drug repurposing and as our Scientific Research Director, Dr. Laura Kleiman founded Reboot Rx, the tech nonprofit using AI and machine learning to determine which generic drugs are most promising for treating cancer. https://t.co/iMcAxUfROZ

Coffee consumption associated with improved survival in patients with metastatic colorectal cancer — new study published in @JamaOnc: https://t.co/dNEYonN8Pp @ng_kimmie @DFarberYoungCRC #CRCSM https://t.co/6GDEmIdn2v

Dana-Farber scientists are helping lead an array of clinical trials of potential treatments for COVID-19. https://t.co/xUPmkix1eD

Register today for the #BostonMarathon @TheJimmyFund Walk on Sunday, 10.4. While the event won’t physically be on the course this year, it will continue to raise funds for pediatric and adult cancer research at @DanaFarber. Register now at https://t.co/L99Zj2l6Op. #JimmyFundWalk https://t.co/BDMqNpge1h

Register today for the #BostonMarathon @TheJimmyFund Walk on Sunday, 10.4. While the event won’t physically be on the course this year, it will continue to raise funds for pediatric and adult cancer research at @DanaFarber. Register now at https://t.co/L99Zj2l6Op. #JimmyFundWalk https://t.co/BDMqNpge1h

Hear from Nikhil Munshi, MD, and his patient Alfred Johnson on the innovative research taking place at Dana-Farber to transform care for all patients and survivors: https://t.co/NS1nHSj4p0 #CancerDisparitiesReport #HealthEquity #mmsm 👇 https://t.co/ZLwOGDKyGa

Next Page